Addison Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Addison Advisors's NVS Position: Q1 2026 in Review
Addison Advisors reduced its Novartis (NVS) stake by 0.67% in Q1 2026, selling an estimated $3.22K and leaving 3,132 shares worth $478K. The position accounts for 0.11% of the portfolio, ranked #134.
Addison Advisors first reported a position in NVS in Q4 2020 and has held it in 21 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Addison Advisors held 3,132 shares of Novartis worth $478K as of Q1 2026.
- Addison Advisors sold 21 Novartis shares in Q1 2026, an estimated $3.22K.
- Novartis made up 0.11% of Addison Advisors's portfolio in Q1 2026, its #134 holding.
- Addison Advisors first reported a position in Novartis in Q4 2020 and has held it in 21 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.